Bob Geldof and Midge Ure have announced that some of today s biggest chart stars will help raise money to fight the spread of Ebola in West Africa, by recording a new version of Do They Know It s Christmas?
Bob Geldof and Midge Ure have announced that some of today s biggest chart stars will help raise money
When the song was originally released 30 years ago, a number of today's biggest pop acts weren't even born. But Bob Geldolf openly welcomed in the likes of Rita Ora (top right) and pop heart-throbs One Direction (Harry Styles, top centre) as he re-recorded his classic charity track Do They Know It's Christmas? in London on Saturday. Geldof (pictured main with co-writer Midge Ure) was among the first to arrive, looking upbeat as he made his way into Notting Hill's Sarm Studios ahead of Ellie Goulding (bottom centre) and Coldplay's Chris Martin (bottom right). Starbucks drinks that were delivered to the studio in crates (inset top) kept the stars energise as they record the track, set to be released on Monday.
IRELAND AND ISRAEL HEALING THE WORLD
YET AGAIN THE WORLD LOOKS TOWARDS ISRAEL AS IT DEVELOPS A CURE FOR EMBOLA ....THANK ISRAEL
An Israeli bio pharmaceutical company said that it has the resources to produce ZMapp – the drug that can potentially cure Ebola.
The death toll from the Ebola epidemic has climbed above 2,000, the World Health Organisation (WHO) said Friday, as it voiced hopes a vaccine could be available in November.
However, supplies of experimental medicines — including the prototype drug ZMapp — are limited, and “will not be sufficient for several months to come,” the World Health Organisation (WHO) warned Friday.
Protalix, an Israeli bio pharmaceutical company, said that it has the resources to produce the coveted ZMapp, which has recently run out, Israeli site The Times of Israel, citing Channel 2 TV‘s report, said Sunday.
Thank you Israel for the following.....
Eshkol-Wachman Movement Notation – a notation system for recording movement on paper that has been used in many fields, including dance, physical therapy, animal behavior and early diagnosis of autism.
Development of Azilect, a drug for Parkinson's disease, by Moussa Youdim and John Finberg from the Technion - Israel Institute of Technology, and commercialized by Teva Pharmaceutical Industries.
Development of the Copaxone immunomodulator drug for treating multiple sclerosis. It was developed in the Weizmann Institute of Science in Israel by Michael Sela, Ruth Arnon and Deborah Teitelbaum.[16][17]
Development of the Interferon proteins by Michel Revel from the Weizmann Institute of Science in Israel.[
Development of taliglucerase alfa (Elelyso), a recombinant glucocerebrosidase enzyme produced from transgenic carrot cell cultures.[19] Taliglucerase alfa won approval from the U.S. Food and Drug Administration in May 2012 as an orphan drug for the treatment of Type 1 Gaucher's disease.
No comments:
Post a Comment